We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+10.76%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$138B
AUM Growth
+$19.4B
(+16%)
Cap. Flow
+$7.6B
Cap. Flow
% of AUM
5.51%
Top 10 Holdings %
Top 10 Hldgs %
15.42%
Holding
4,486
New
399
Increased
2,092
Reduced
1,353
Closed
351
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.28B |
| 2 |
Microsoft
MSFT
|
+$517M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$351M |
| 4 |
Apple
AAPL
|
+$302M |
| 5 |
Wells Fargo
WFC
|
+$242M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$685M |
| 2 |
Vanguard Extended Market ETF
VXF
|
+$566M |
| 3 |
Entergy
ETR
|
+$367M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$340M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$253M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.22% |
| 2 | Technology | 11.9% |
| 3 | Financials | 9.98% |
| 4 | Consumer Discretionary | 7.32% |
| 5 | Communication Services | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXK
3901
Endeavour Silver
EXK
$2.23B
| $165K | ﹤0.01% |
68,534
+15,675
| +30% | +$35.6K |
|
3902
Covenant Logistics
CVLG
$894M
| $162K | ﹤0.01% |
24,998
-4,178
| -14% | -$30.3K |
|
|
SWIR
3903
DELISTED
Sierra Wireless
SWIR
| $162K | ﹤0.01% |
16,901
-589
| -3% | -$5.73K |
|
|
ECOM
3904
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $161K | ﹤0.01% |
17,791
-3,434
| -16% | -$31.5K |
|
3905
Geron
GERN
$828M
| $160K | ﹤0.01% |
117,371
-29,078
| -20% | -$42K |
|
3906
BlackRock MuniYield New York Quality Fund
MYN
$372M
| $160K | ﹤0.01% |
12,200
| – | – |
|
3907
Green Brick Partners
GRBK
$3.04B
| $157K | ﹤0.01% |
13,659
-3,762
| -22% | -$41.1K |
|
|
CNSL
3908
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $157K | ﹤0.01% |
40,519
-12,311
| -23% | -$47.3K |
|
3909
Inovio Pharmaceuticals
INO
$55.7M
| $156K | ﹤0.01% |
3,915
-3,138
| -44% | -$94.4K |
|
|
RUBY
3910
DELISTED
Rubius Therapeutics, Inc
RUBY
| $156K | ﹤0.01% |
16,461
-5,357
| -25% | -$51.8K |
|
|
OCFT
3911
DELISTED
OneConnect Financial Technology
OCFT
| $154K | ﹤0.01% |
+1,541
| New | +$153K |
|
3912
Lifecore Biomedical
LFCR
$166M
| $153K | ﹤0.01% |
13,540
-2,804
| -17% | -$29.8K |
|
3913
Avita Medical
RCEL
$135M
| $152K | ﹤0.01% |
+3,331
| New | +$138K |
|
3914
Scholar Rock
SRRK
$5.67B
| $152K | ﹤0.01% |
11,572
-2,309
| -17% | -$22.2K |
|
3915
Citizens
CIA
$239M
| $151K | ﹤0.01% |
22,459
-12,195
| -35% | -$83.9K |
|
|
JE
3916
DELISTED
Just Energy Group Inc
JE
| $151K | ﹤0.01% |
2,718
-2,523
| -48% | -$181K |
|
|
LBC
3917
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $143K | ﹤0.01% |
12,460
+1,424
| +13% | +$16.2K |
|
|
CEL
3918
DELISTED
Cellcom Israel, Ltd.
CEL
| $143K | ﹤0.01% |
45,222
+19,922
| +79% | +$54K |
|
|
CURO
3919
DELISTED
CURO Group Holdings Corp.
CURO
| $142K | ﹤0.01% |
11,690
-2,063
| -15% | -$27.6K |
|
3920
TELA Bio
TELA
$32.7M
| $141K | ﹤0.01% |
+10,900
| New | +$133K |
|
|
GNMK
3921
DELISTED
GenMark Diagnostics, Inc
GNMK
| $141K | ﹤0.01% |
29,429
-12,363
| -30% | -$68.2K |
|
3922
Applied Optoelectronics
AAOI
$7.57B
| $139K | ﹤0.01% |
11,731
-12,719
| -52% | -$136K |
|
3923
BBVA Argentina
BBAR
$3.87B
| $139K | ﹤0.01% |
24,873
-157,833
| -86% | -$651K |
|
3924
Ultrapar
UGP
$6.95B
| $139K | ﹤0.01% |
22,198
| – | – |
|
3925
Intrepid Potash
IPI
$456M
| $138K | ﹤0.01% |
5,106
-1,544
| -23% | -$41.9K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q4 2019 Portfolio in Review
As of Q4 2019, Credit Suisse held 4,486 positions worth $138B, up 16% from $119B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Credit Suisse deployed $7.6B of net new capital in Q4 2019, opening 399 new positions and adding to 2,092 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 1,727,952 shares worth $76M.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard Extended Market ETF, an estimated $566M trimmed.
- Credit Suisse's largest Q4 2019 buy was iShares Russell 1000 Growth ETF: 1,727,952 shares worth $76M.
- Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $1.28B increase.
- Credit Suisse's biggest Q4 2019 reduction was Vanguard Extended Market ETF, cutting an estimated $566M.
- Credit Suisse fully exited Celgene Corp in Q4 2019, selling an estimated $685M.
- Credit Suisse's ten largest holdings make up 15% of its $138B portfolio in Q4 2019.
- Credit Suisse opened 399 new positions and closed 351 in Q4 2019.
- Credit Suisse's portfolio value rose 16% quarter-over-quarter to $138B.
Based on Credit Suisse's 13F filing for Q4 2019, filed 12 Feb 2020.